TransUnion saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, with an upgrade from 66 to 78.
IBD's unique RS Rating identifies technical performance by using a 1 (worst) to 99 (best) score that identifies how a stock's price performance over the last 52 weeks compares to other publicly traded companies.
Decades of market research reveals that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 as they begin their largest price moves. See if TransUnion can continue to rebound and hit that benchmark.
When To Sell Stocks To Lock In Profits And Minimize Losses
TransUnion is working on a consolidation with a 113.17 buy point. See if it can break out in heavy trading.
While sales growth fell last quarter from 12% to 9%, earnings-per-share grew 21%, up from 14% in the previous report.
TransUnion earns the No. 14 rank among its peers in the Financial Services-Specialty industry group. Marex Group, Sezzle and Corpay are among the top 5 highly rated stocks within the group.
RELATED:
IBD Stock Rating Upgrades: Rising Relative Strength
Why Should You Use IBD's Relative Strength Rating?
How Relative Strength Line Can Help You Judge A Stock
Ready To Grow Your Investing Skills? Join An IBD Meetup Group!
